支气管镜介入治疗用抗结核药物缓释剂的研究
发布时间:2018-06-23 13:09
本文选题:支气管镜 + 肺结核 ; 参考:《河北大学》2013年硕士论文
【摘要】:耐药结核病的产生给结核病的治疗带来了新的难题,使常规的治疗手段很难达到满意的治疗效果。支气管镜介入治疗是一种可直视病灶局部的靶向治疗方式,其投递药物多为口服或静脉真溶液药物或凝胶药物,虽然靶向性强、药物剂量控制准确,但是药物的缓释效果差,肺内的呼吸挤压还会阻碍凝胶药物向远端注入,影响治疗效果。因此本课题选择水溶性药物环丙沙星作为研究对象,开发其缓释微粒,作为支气管镜介入治疗用专属药物。 本研究以壳聚糖作为药物载体,环丙沙星作为研究药物,应用乳化交联法制备环丙沙星壳聚糖微球,并对其粒径、粒径分布、载药量、包封率、通透性、降解度、肺部滞留性,缓释性,安全性等方面进行评价,进而评估其经支气管镜介入给药的可行性,以期达到抗结核药物环丙沙星肺部缓慢持续释放,减少给药次数,提高患者顺应性的目的。 第一部分:环丙沙星壳聚糖微球的制备及体外释放初步研究 制备支气管镜介入治疗用环丙沙星缓释微球,并通过考察环丙沙星壳聚糖微球多种影响因素,并对其表征及理化性质进行评价,筛选出适合支气管镜介入治疗用处方工艺。以戊二醛作为交联剂,采用乳化交联法制备环丙沙星壳聚糖缓释微球,,正交实验设计筛选处方工艺,并应用扫描电镜、激光粒度仪、UV等检测手段对其形态、粒径、载药量、包封率及恒温条件下体外释放度等指标进行测定。制备的环丙沙星壳聚糖微球球型完整,球体光滑,粒度分布均匀符合正态性分布,80%以上的微球粒径大小120-160μm,平均粒径(142.31±7.85)μm,平均载药量(14.20±0.61)%,平均包封率(56.43±1.31)%。该微球能顺利通过7号针头,可经支气管镜介入导管顺畅注射。在恒温条件下,壳聚糖微球缓释时间可达到48h,较明显的延缓了水溶性药物的释放时间。 第二部分:环丙沙星壳聚糖多重交联微球的制备及体外评价 为了更有效的延缓环丙沙星药物的释放时间,选取非离子型表面活性剂乙基纤维素作为辅料,制备环丙沙星壳聚糖-乙基纤维素多重交联微球。采用乳化交联法制备多重交联微球,以体外释放度作为主要参考指标,通过正交实验结果优化处方,综合考察该处方工艺制备的多重交联微球,对其体外释放度、体外降解度等情况进行评价。对处方条件下制备的壳聚糖缓释微球的形态、粒径分布、Zeta电位等指标进行检测,评定该多重交联微球的表征。制备3批壳聚糖载药微球,呈肉眼颗粒状,光镜观察球型圆整,黏连较少,电镜观察球体表面光滑,但存在少量褶皱;粒度分布均匀,平均粒径(142.31±7.85)μm,平均Zeta电位值为(51.68±2.3)mV;在恒温条件下,多重交联微球缓释时间可达到144h,较普通壳聚糖微球表现出更出色的缓释效果,更加明显的延缓了水溶性药物的释放时间,为接下来的体内实验提供了研究依据,更进一步的达到了支气管镜介入给药后靶向缓释的研究目的。 第三部分:缓释系统体内生物相容性及安全性的初步研究 综合考察该处方工艺制备的载药微球,需对其药效学、药动学及毒理学指标进行评价。通过兔肺内注入载药微球,考察2周内不同组别兔体温、进食、活动性等方面的变化,发现兔没有表现出明显的热源反应及表观生理性变化,较空白组无显著性差异;通过兔肺内注射自制的载药微球,考察其肺局部组织病理学变化及肺内滞留性,研究发现载药微球表现出很好的肺内滞留性,虽然体内降解实验中,28天载药微球未见完全降解,但兔呼吸正常,肺内支气管粘膜各层结构清晰可见,形态正常,肺泡结构完整,无间隙红细胞增多、肺泡间隔增厚等病理学改变。该方法制备的载药微球具有较出色的生物相容性及体内安全性,具有进一步开发支气管镜介入用专属缓释药物的可行性和必要性。
[Abstract]:The present invention relates to a targeting therapeutic method for treating tuberculosis , which has the advantages of strong targeting property and accurate drug dosage control , but the slow release effect of the drug is poor , and the slow release effect of the drug is affected .
Chitosan was used as the drug carrier , ciprofloxacin was used as the study drug , and its particle size , particle size distribution , drug loading , encapsulation efficiency , permeability , degradability , lung retention , sustained release and safety were evaluated .
The first part : preparation of ciprofloxacin chitosan microspheres and preliminary study on in vitro release
The microspheres were prepared by using glutaraldehyde as cross - linking agent . The microspheres were prepared by using glutaraldehyde as cross - linking agent . The microspheres were prepared by emulsion crosslinking method . The average particle size ( 14.20 卤 0.61 ) % , the average particle size ( 142.31 卤 7.85 ) 渭m , the average particle size ( 14.20 卤 0.61 ) % , the average entrapment efficiency ( 56.43 卤 1.31 ) % .
The second part : preparation and in vitro evaluation of ciprofloxacin chitosan multiple cross - linked microspheres
In order to delay the release time of ciprofloxacin drugs more effectively , the non - ionic surfactant ethyl cellulose was selected as the auxiliary material to prepare the ciprofloxacin chitosan - ethyl cellulose multiple cross - linked microspheres .
The average particle size distribution was ( 142.31 卤 7.85 ) 渭m and the average zeta potential was ( 51.68 卤 2.3 ) mV .
Under the constant temperature condition , the sustained - release time of the multiple cross - linked microspheres can reach 144h , the chitosan microspheres show better sustained - release effect , the release time of the water - soluble drug is obviously delayed , the research basis is provided for the following in vivo experiments , and further , the research purpose of targeting sustained release after the interventional administration of the bronchoscopic mirror is achieved .
The third part : preliminary study on biocompatibility and safety of sustained - release system
The pharmacodynamics , pharmacokinetics and toxicological indexes of the drug - loaded microspheres prepared by the prescription were evaluated . The changes of body temperature , feeding and activity of different groups in rabbits were investigated by injecting drug - loaded microspheres into the lung of rabbits .
The pathological changes of lung and the retention of lung were investigated by injection of self - made drug - loaded microspheres in rabbit lung . The results showed that the drug - carrying microspheres showed good intrapulmonary retention . Although the drug - loaded microspheres were not completely degraded in 28 - day drug - loaded microspheres , the structure of the lung was normal , the alveolar structure was intact , no gap erythrocytes were increased , and the thickening of alveolar septum was changed . The drug - loaded microspheres prepared by the method have excellent biocompatibility and in vivo safety , and have the feasibility and the necessity of further developing the sustained - release drug for the interventional therapy of the bronchoscopic mirror .
【学位授予单位】:河北大学
【学位级别】:硕士
【学位授予年份】:2013
【分类号】:R521;R96
【参考文献】
相关期刊论文 前10条
1 傅红梅;肖們;廖锦良;方琼;;经支气管镜灌洗注药治疗空洞型肺结核疗效分析[J];广东医学;2008年05期
2 陈江燕,邬国铭;纤维素酶对壳聚糖降解作用的研究[J];广东医学院学报;2003年02期
3 赵江;蒋国强;孙佳丽;张阔;丁富新;;释药用壳聚糖温敏凝胶体内外形态与溶蚀降解研究[J];高校化学工程学报;2010年03期
4 陈书峰;胡杨洋;杨放;金义光;姚洁;李蔷薇;;抗结核药物新剂型-异烟肼药质体的研究[J];国外医药(抗生素分册);2010年03期
5 陈素丽;李艳坤;李幸彬;张广宇;;经支气管镜局部给药治疗复治肺结核疗效观察[J];河北医药;2006年08期
6 杨占娴;宫永宽;;高包封率异烟肼类脂质体的制备与性质研究[J];化学学报;2011年05期
7 周孙英,余萍,陈盛;溶菌酶对壳聚糖降解的研究[J];中国海洋药物;2002年06期
8 张霞;董迎华;李洪敏;王巍;冯端浩;;含异烟肼凝胶药物介入治疗肺结核病安全性分析[J];临床肺科杂志;2008年12期
9 王丽媛;;全身化疗联合超声雾化吸入抗痨药治疗开放型肺结核疗效观察[J];临床肺科杂志;2010年07期
10 闫继红;孙海梅;尚宏伟;张立新;路欣;;可注射性壳聚糖基温敏性凝胶的制备及其生物相容性[J];吉林农业大学学报;2011年05期
本文编号:2057216
本文链接:https://www.wllwen.com/yixuelunwen/huxijib/2057216.html
最近更新
教材专著